Home/Filings/4/0001610717-23-000363
4//SEC Filing

Lanfear Dennis M 4

Accession 0001610717-23-000363

CIK 0001512762other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 4:04 PM ET

Size

12.3 KB

Accession

0001610717-23-000363

Insider Transaction Report

Form 4
Period: 2023-11-22
Lanfear Dennis M
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2023-11-22$1.42/sh+258,940$366,918954,793 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-11-22299,9400 total
    Exercise: $1.42Exp: 2023-11-22Common Stock (299,940 underlying)
  • Exercise/Conversion

    Common Stock

    2023-11-22$1.42/sh+41,000$58,097695,853 total
  • Sale

    Common Stock

    2023-11-22$2.02/sh223,100$449,770731,693 total
Holdings
  • Common Stock

    (indirect: By LLC)
    86,965
  • Common Stock

    (indirect: By Trust)
    432,684
Footnotes (6)
  • [F1]For part of the stock option, this represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price and anticipated taxes.
  • [F2]For the remaining part of the stock option, this represents a cashless exercise-and-hold transaction where only enough shares were sold to cover the exercise price, anticipated taxes and broker's fee, and the remaining shares were held by the Reporting Person.
  • [F3]This transaction was executed in multiple trades at prices ranging from $2.000 to $2.055. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
  • [F5]These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.
  • [F6]The underlying shares subject to the option vested and became exercisable in successive, equal monthly installments over four years measured from July 20, 2013.

Documents

1 file

Issuer

Coherus BioSciences, Inc.

CIK 0001512762

Entity typeother

Related Parties

1
  • filerCIK 0001420822

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:04 PM ET
Size
12.3 KB